Litcius/Paper detail

550O Safety and efficacy of D-1553 in combination with cetuximab in KRAS G12C mutated colorectal cancer (CRC): A phase II study

R-H. Xu, Ye Xu, Dongyao Yan, Pamela N. Münster, Dan Ruan, Yanhong Deng, Hongming Pan, Craig Underhill, Gary Richardson, Ina Nordman, Kyung-Woo Lee, Suocheng Wei, X. Li, Jing Shan, Guohong Han, Steve Henderson, Xinxin Xie, Z. Xiang, Z. Shi, Li Zhang

2023Annals of Oncology14 citationsDOIOpen Access PDF

Topics & Concepts

KRASMedicineCetuximabInternal medicineColorectal cancerOncologyPhases of clinical researchCancerGastroenterologyClinical trialColorectal Cancer Treatments and StudiesLung Cancer Treatments and MutationsGenetic factors in colorectal cancer
550O Safety and efficacy of D-1553 in combination with cetuximab in KRAS G12C mutated colorectal cancer (CRC): A phase II study | Litcius